Foundayo (orforglipron) titration schedule — straight from the FDA label
By The LeanGLP Team · Label information verified 2026-08-05
Foundayo is orforglipron, a once-daily oral tablet (small-molecule GLP-1 receptor agonist) from Eli Lilly. Weight management in adults with obesity, or overweight with at least one weight-related condition — per the prescribing information. Approved April 2026; the first GLP-1 pill that can be taken any time of day with or without food.
Dose-escalation schedule (per the prescribing information)
| Period | Dose | Label note |
|---|---|---|
| Days 1-30 (minimum) | 0.8 mg once daily | |
| After ≥30 days | 2.5 mg once daily | |
| After ≥30 days | 5.5 mg once daily | |
| After ≥30 days per step, based on response and tolerability | May increase to 9 mg, then 14.5 mg, then 17.2 mg once daily |
Maintenance dosing
Maximum dosage: 17.2 mg once daily. Escalation beyond 5.5 mg is based on treatment response and tolerability, per the label.
Plain-language notes
- Tablets are swallowed whole — do not break, crush, or chew — with or without food, no water restriction. That is a meaningful practical difference from oral semaglutide's empty-stomach rules.
- The label's escalation steps are ~30-day minimums (daily dosing), versus the 4-week weekly-injection steps of the injectables.
Why the slow ramp exists
Every GLP-1 label escalates gradually for the same stated reason: reducing gastrointestinal side effects while the body adapts. For nutrition planning, the escalation window is when appetite suppression tends to hit hardest — which is exactly when protein intake usually craters. That's the problem our GLP-1 protein calculator and week-one meal plan are built for.
Sources
- Foundayo U.S. Prescribing Information (FDA, 2026 approval)
- Lilly medical: approved dosing for Foundayo (orforglipron)
Schedules can change when the FDA approves label revisions — the links above always point at the current official documents. If you spot a discrepancy, tell us and we'll correct it fast.
Frequently asked questions
Does orforglipron (Foundayo) have food or water restrictions?
No — per the prescribing information it is taken once daily with or without food, and tablets are swallowed whole. That differs from oral semaglutide, which requires an empty stomach and a 30-minute wait.
What is the starting dose of Foundayo?
Per the label: 0.8 mg once daily for at least 30 days, then 2.5 mg, then 5.5 mg, each after at least 30 days on the prior dose. Doses may be increased to 9, 14.5, or up to a maximum of 17.2 mg daily based on response and tolerability.